The Efficacy in Treatment of Facial Melasma Combined With Thulium 1927-nm Fractional Laser and Topical H2R Antagonist

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

November 25, 2023

Study Completion Date

November 25, 2023

Conditions
Melasma
Interventions
COMBINATION_PRODUCT

topical H2R antagonist

Topical H2RA (2% famotidine solution solved in double-distilled water (containing poloxamer 407, glycerol, lauryl alcohol polyether-4, polyethylene glycol-8, and propylene glycol)) was applied topically twice per day in the morning and the evening for 16 weeks.

DEVICE

Thulium 1927-nm Fractional Laser

1927nm fractional laser (South Korea, WONTECH, Lavieen) was performed with 4-week interval (Week 0, 4, 8, 12 and 16) for a total of 4 treatments. The parameter of 1927nm fractional laser was as follows: duration 600-800um, 10w, density 0.8mm, 1 pass.

Trial Locations (1)

710000

The second affiliated hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors
lead

Second Affiliated Hospital of Xi'an Jiaotong University

OTHER